Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 37Terminated 20Active not recruiting 3Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Sertoli-Leydig Cell Tumor 1Ovarian gynandroblastoma 1Granulosa cell tumor of the ovary 1

Interventions

Carboplatin 8Paclitaxel 7Taxes 6Cisplatin 6pembrolizumab 5Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Platinum 4Fluorouracil 4Capecitabine 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Conformal 3Metformin 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Brachytherapy 3folfirinox 2aumolertinib 2Radiotherapy 2Proton Therapy 2Prednisone 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Ifosfamide 2Gemcitabine 2Folfox protocol 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × etoposide phosphate × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡